BETNESOL 4 mg/1 ml, solution for injection 3 ampoules of 1 ml
Active ingredients: Betamethasone sodium phosphate, Betamethasone
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection3 ampoules of 1 mlendosinusale;intraarticulaire;intralésionnelle;intramusculaire;intraveineuse;périarticulaire;sous-conjonctivale;voie parentérale autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BETNESOL 4 mg/1 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- endosinusale;intraarticulaire;intralésionnelle;intramusculaire;intraveineuse;périarticulaire;sous-conjonctivale;voie parentérale autre
- Presentation description
- 3 ampoule(s) en verre de 1 ml
- Marketing authorisation holder
- ALFASIGMA (ITALIE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Oct 1963
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60152607CIP73010967CIP133400930109670Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BÉTAMÉTHASONEsolution | 4,0 mg · une ampoule de 1,0 ml | FT |
| BÉTAMETHASONE (PHOSPHATE DE) ET DE DISODIUMsolution | 5,3 mg · une ampoule de 1,0 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.